Clinical Trial Update: Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on the efficacy and safety of inhaled budesonide in very preterm infants at risk for bronchopulmonary dysplasia; the study status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Drugs mentioned

• Budesonide (BUDESONIDE)

Snippet

Sponsor: University Children's Hospital Tuebingen | Conditions: Bronchopulmonary Dysplasia | Phase 3 | Status: COMPLETED